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Summary
 
It is well established that lymphoid dendritic cells (DC) play an important role in the immune
system. Beside their role as potent inducers of primary T cell responses, DC seem to play a cru-
cial part as major histocompatibility complex (MHC) class II
 
1
 
 “interdigitating cells” in the thy-
mus during thymocyte development. Thymic DC have been implicated in tolerance induction
and also by some authors in inducing major histocompatibility complex restriction of thy-
mocytes. Most of our knowledge about thymic DC was obtained using highly invasive and
manipulatory experimental protocols such as thymus reaggregation cultures, suspension cul-
tures, thymus grafting, and bone marrow reconstitution experiments. The DC used in those
studies had to go through extensive isolation procedures or were cultured with recombinant
growth factors. Since the functions of DC after these in vitro manipulations have been reported
to be not identical to those of DC in vivo, we intended to establish a system that would allow
us to investigate DC function avoiding artificial interferences due to handling. Here we present
a transgenic mouse model in which we targeted gene expression specifically to DC. Using the
CD11c promoter we expressed MHC class II I-E molecules specifically on DC of all tissues, but
not on other cell types. We report that I-E expression on thymic DC is sufficient to negatively se-
lect I-E reactive CD4
 
1
 
 T cells, and to a less complete extent, CD8
 
1
 
 T cells. In contrast, if only DC
expressed I-E in a class II–deficient background, positive selection of CD4
 
1
 
 T cells could not
be observed. Thus negative, but not positive, selection events can be induced by DC in vivo.
 
S
 
ignaling through the TCR/CD3 complex of immature
CD4
 
1
 
CD8
 
1
 
 thymocytes can induce at least two differ-
ent developmental events: negative selection resulting in
cell death or positive selection resulting in maturation of
thymocytes (1–3). This signaling, however, can have different
outcomes depending on the type of stromal cell that pre-
sents MHC/peptide complexes to the developing thymo-
cytes. Yet, some controversy still exists with respect to the rel-
ative capacities of epithelial- or bone marrow (BM)
 
1
 
-derived
cells in inducing apoptosis or positive selection. For negative
selection, results varied according to the in vitro experimental
system used. Thus, in suspension cultures, BM-derived
cells were as efficient as epithelial cells in deleting self-reac-
tive thymocytes (4, 5), whereas in the case of reaggregation
cultures, they were shown to be much better deleters than
epithelial cells (6, 7). The precise function of each BM-
derived cell type (dendritic cells [DC], macrophages, or B
cells), however, remains relatively unclear. While macro-
phages are probably not able to clonally eliminate self-reactive
thymocytes (8), it has been postulated that thymic DC could
do so only in concert with B cells (9).
Early experiments involving MHC mismatched BM–
chimeras suggested that thymic epithelial cells were respon-
sible for inducing the maturation of immature thymocytes
to mature single-positive T cells (reviewed in reference 1).
These results were questioned by several experiments show-
ing that many different cell types, such as fibroblasts (10,
11) or BM-derived cells (12), were able to mediate positive
selection in some, but not in all cases (13), when injected
intrathymically or used in BM reconstitution experiments.
Interestingly, in more recent thymus reaggregation experi-
ments, neither DC from spleen (1 4) nor thymic DC that
was expanded in vitro with the help of recombinant GM-
CSF (15, 16) were able to mediate positive selection. Dif-
ferences in surface marker expression between thymic and
splenic DC have been reported (17, 18), and it has been
shown that short-term cultured DC differ phenotypically
and functionally from their freshly isolated counterparts
(19). Since the highly artificial experimental setups and ex-
tended handling of DC and thymocytes in vitro might have
had an influence on the functions and properties of these
cells (20), we wanted to investigate the role of thymic DC
 
1
 
Abbreviations used in this paper:
 
 BM, bone marrow; DC, dendritic cells;
FS, forward scatter; SS, side scatter.
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in an unmanipulated, non-invasive in vivo system. To this
end, we developed a transgenic model in which transgene
expression was directed exclusively to DC due to an appro-
priate promoter. We eventually selected the mouse CD11c
promoter because the expression of CD11c 
 
b
 
2
 
 integrin, as
detected by the mAb N418 (21), was restricted to mouse
DC in spleen (21) or other tissues (22) including thymus
(22, 23), and therefore represented the best marker avail-
able for mouse DC.
Here we present our findings obtained with such a DC-
specific expression system. We used the MHC class II I-E
 
a
 
gene as a transgene in the I-E-negative C57Bl/6 background
and describe a DC-specific expression pattern in the thy-
mus. We could not detect transgene expression on thymic
epithelium, B cells, nor macrophages and describe in this
model that thymic DC were able to negatively select self-
I-E–reactive T cells. The completeness of the deletion
clearly demonstrates that thymic DC alone are sufficient to
induce tolerance via clonal deletion. Further, when in an
MHC class II–deficient background, only thymic DC ex-
press I-E, and CD4
 
1
 
 T cells are not positively selected, es-
tablishing that thymic DC in vivo are not able to induce
positive selection.
 
Materials and Methods
 
Isolation of Genomic Clones, DNA Constructs, and Microinjection.
 
A cDNA pool from four human T cell clones, all expressing hu-
man CD11c, was used as template for PCR amplification. The
sense oligonucleotide corresponded to 40 bp of human 
 
CD11c
 
–
exon 7 (5
 
9
 
-TGCCACGATGATGAACTTCGTGAGAGCTG-
TGATAAGCCAG-3
 
9
 
), while the antisense oligonucleotide was
located within human 
 
CD11c
 
–exon 11 (5
 
9
 
-CCATGTCCAAT-
TCGAAGGAGCTACTGCTTGTGGTCTCCGT-3
 
9
 
) (24). The
amplified human 
 
CD11c
 
 gene fragment was sequenced and then
used as a probe to screen a mouse genomic library (OLA 129-
 
l
 
GEM
 
TM
 
-12-bank, gift of Dr. A. Berns, The Netherlands Can-
cer Institute, Amsterdam, Netherlands). We isolated two overlap-
ping phages that were characterized by restriction mapping and
partial sequencing of their inserts. DNA-sequence analysis of
 
z
 
1,000 bp around the initiation codon showed 68.8% identity to
the corresponding sequence of the human 
 
CD11c
 
 gene and were
therefore accepted to represent mouse 
 
CD11c.
 
 We used a 5.5-kb
Sst I-BspHI (blunt) fragment that contained the 5
 
9
 
 region of mouse
 
CD11c
 
 gene to drive the expression of the transgene. This fragment
was cloned into a SmaI-SstI–opened pBSbluescript vector that
contained a blunted 1.2-kb BamHI-XhoI fragment from pDOI-5
(25) in its blunt-ended EcoRI site. This rabbit 
 
b
 
-globin gene frag-
ment provided the transgene with an intron and a polyadenylation
signal (25). The cDNA encoding I-E
 
a
 
d
 
 was isolated from the B
lymphoma A20 with the oligonucleotides 5
 
9
 
-ACCCAAGAAGAA-
AATGGCCACAATT-3
 
9
 
 and 5
 
9
 
-TACTTACCTCCAGGTATC-
TCACAGGGCTCCTTG-3
 
9
 
 and confirmed by DNA sequencing.
The I-E
 
a
 
d
 
 cDNA was cloned as a blunt-end fragment into the
blunted EcoRI site of the rabbit 
 
b
 
-globin gene. After digestion with
XhoI and NotI, the transgene DNA was separated from the vec-
tor sequences by electrophoresis, extracted from agarose slices, and
resuspended in Tris-EDTA buffer (10 mM Tris, pH 7.4, 0.1 mM
EDTA). Fertilized oozytes were obtained from C57Bl/6 mice,
and DNA injection was performed as previously described (26).
 
Monoclonal Antibodies and Reagents.
 
The mAbs specific for CD4
(No. 09005), CD8 (No. 01044), V
 
b
 
8.1/8.2 TCR (No. 01344),
V
 
b
 
5.1/5.2 TCR (No. 01354), V
 
b
 
11 TCR (No. 01374), I-E
 
a
 
k
 
(No. 09625), CD11c (No. 09705), and CD19 (No. 09655) were
purchased from PharMingen (San Diego, CA). Anti-CD8 R613
(GIBCO BRL, Gaithersburg, MD) was used for the three-color
fluorescence analysis. Goat anti–rat IgG serum (No. 3010-02; South-
ern Biotechnology Assoc., Birmingham, AL) was used as second step
reagent and MTS-10 ([27], gift of Dr. H.R. Rodewald, Basel Insti-
tute for Immunology, Basel, Switzerland), a mAb specific for medul-
lary thymic epithelial cells, was used as culture supernatant. UEA-1,
a fucose-specific lectin-staining medullary, but not cortical, epithe-
lium (28) was purchased from Vector Labs., Inc. (Burlingame, CA).
 
Immunohistology.
 
Fresh organs were embedded in OCT me-
dium (No. 4583; Miles-Yeda Inc., Elkhart, IN), snap frozen, and
6 
 
m
 
m sections were cut with a cryostat. Sections were air dried
for 60 min, acetone-fixed for 2 min, and air dried for a minimum
of 12 h. Sections were then rehydrated in PBS (containing 1%
BSA and 10% normal mouse serum). mAbs diluted in PBS/BSA/
normal mouse serum were added directly onto the sections and
incubated for 60 min. After washing, the sections were either di-
rectly mounted in Fluoromount for immunofluorescence analysis
or incubated with the second step reagent and then mounted and
analyzed.
For immunohistological stainings, we used biotinylated mAbs
and alkaline phosphatase-conjugated streptavidin (No. RPN 1234;
Amersham Intl., Buckinghamshire, UK) as a second step reagent.
The color reaction was then developed (Vector-Red Alkaline Phos-
phatase Substrate Kit No. SK-5100; Vector Labs., Inc.) according
to manufacturer’s instructions.
 
Isolation of Thymic DC and B Cells.
 
Thymi of different mice
were digested twice with collagenase (CLSPA; Worthington Bio-
chemical Corp., Freehold, NJ) for 30 min at 37
 
8
 
C as described
previously (29). Cells were then recovered by centrifugation at
300 
 
g
 
 for 5 min, and resuspended in a 17% Optiprep
 
TM
 
 (Nycomed
Pharma, Oslo, Norway) solution diluted in Hank’s balanced salt so-
lution without Ca
 
2
 
1
 
 and Mg
 
2
 
1
 
. They were then overlaid with
12% Optiprep
 
TM
 
 diluted in 0.88% (wt/vol) NaCl, 1 mM EDTA,
10 mM Hepes, 0.5% BSA, pH 7.4, and 2 ml Hank’s without
Ca
 
2
 
1
 
 and Mg
 
2
 
1
 
, respectively, and centrifuged at 600 
 
g
 
 for 15 min
at 20
 
8
 
C. The low density cells at the Hank’s 12% Optiprep
 
TM
 
 in-
terface were harvested, washed twice, and used as a thymic DC en-
riched fraction.
Thymic B cells were enriched by complement depletion of
CD4
 
1
 
 and CD8
 
1
 
 cells of the thymus. Briefly, thymus was teased
and cells resuspended in PBS, 1% FCS at 30 
 
3
 
 10
 
6
 
 cells/ml. They
were incubated for 10 min at 37
 
8
 
C with 1:10 diluted culture su-
pernatant of 31M (anti-CD8 mAb) and 172 (anti-CD4 mAb). 1 ml
H
 
2
 
O-reconstituted low-tox-M rabbit complement (Cedarlane,
Westbury, NY) was then added to the cells and incubated at
37
 
8
 
C for another 45 min. Living cells were isolated after a Ficoll-
Paque gradient (Pharmacia Biotech, Uppsala, Sweden).
 
Flow Cytometry.
 
Expression of cell surface proteins was as-
sayed by indirect immunofluorescence. Organs were teased
through a mesh and cell suspensions of 1 
 
3
 
 10
 
5
 
 viable cells were
stained with 20 
 
m
 
g/ml mAb that was directly labeled. After wash-
ing, cells were analyzed using a FACScan
 
Ò
 
 (Becton Dickinson,
Mountain View, CA).
 
Results and Discussion
 
Cloning of the Mouse CD11c Promoter Containing Sequences.
 
To isolate the regulatory elements controlling the expres-
sion of CD11c in mice, we screened a mouse genomic li- 
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brary with a probe corresponding to human 
 
CD11c
 
 exon 7
to 11 (see Materials and Methods). The clone we isolated
was partially analyzed by DNA sequencing and showed a
high homology to the published (24, 30) human 
 
CD11c
 
genomic sequences (data not shown). We isolated a 5-kb
fragment of the 5
 
9
 
 region that we expected to contain the
promoter region (see Materials and Methods) and used it as
the controlling element to express the E
 
a
 
d
 
 cDNA in C57Bl/6
mice (Fig. 1). Two founder lines were obtained and the
transgene expression was monitored with 14.4.4S, a mAb
specific for the 
 
a
 
 chain of the I-E MHC class II antigen (31).
Thereafter, these mice are referred to as “B6CD11c-E
 
a
 
d
 
.”
 
Expression Pattern of the I-E
 
a
 
d
 
 Transgene in the Thymus.
 
Two different mouse strains were used as controls. An I-E
transgenic line created by Widera et al. (32) was used as a
“positive” control. This transgenic line 107.1 (throughout
this study called B6-E
 
a
 
d
 
) expresses an I-E
 
a
 
d
 
 transgene under
the control of a segment of the I-E MHC class II promoter.
The expression pattern previously described for the B6-E
 
a
 
d
 
line corresponded to wild-type I-E expression in I-E
 
1
 
strains including cortical and medullary thymic epithelial
cells, as well as the BM-derived thymic fraction. Negative
control mice were C57Bl/6 mice (B6) that did not express
the I-E
 
a
 
 genes, and therefore, no complementation with
the 
 
b
 
 chain could occur, leading to absence of I-E MHC
class II surface expression (33).
Immunohistological analysis of thymi of the three de-
scribed mouse lines is shown in Fig. 2. Serial sections were
incubated with UEA-1, a fucose-specific lectin that stains
medullary epithelial cells (28; Fig. 2, 
 
b
 
, 
 
d
 
, and 
 
f
 
), and
14.4.4S to monitor transgene expression (Fig. 2, 
 
a
 
, 
 
c
 
, and 
 
e
 
).
While B6 thymus does not show any I-E expression (Fig. 2 
 
a
 
)
in medulla (as localized with UEA-1 in Fig. 2 
 
b
 
) or cortex,
the control B6-E
 
a
 
d
 
 thymus (Fig. 2, 
 
c
 
 and 
 
d
 
) could be stained
with 14.4.4S (Fig. 2 
 
c
 
) in medulla as well as in cortical re-
gions. While the medulla (Fig. 2 
 
c
 
, 
 
M
 
) showed a strong
staining due to I-E expression on its BM-derived and epi-
thelial components (32), the cortical area (Fig. 2 
 
c
 
, 
 
C
 
)
stained in a typical reticular lattice pattern due to transgene
expression on cortical epithelial cells (32).
Our transgenic B6CD11c-E
 
a
 
d
 
 thymus (Fig. 2, 
 
e
 
 and 
 
f
 
),
on the other hand, showed a clearly distinct thymic I-E ex-
pression pattern; the staining was confined to the thymic
medulla and corticomedullary junctions (Fig. 2 
 
e
 
, 
 
M
 
). This
I-E expression pattern corresponded exactly to the CD11c
expression pattern in the thymus when the CD11c-specific
mAb N418 was used (data not shown) and was matching
the thymic area where thymic DC had been localized be-
fore (34, 35). Furthermore, in sharp contrast to B6-E
 
a
 
d
 
transgenic thymi (Fig. 2 
 
c
 
 and Fig. 3 a), in B6CD11c-Ea
d
mice no I-E expression was detectable on cortical epithelial
cells (Fig. 2 e and Fig. 3 b) even when a higher magnifica-
tion and more sensitive immunofluorescence technology
was used (Fig. 3 b).
To discriminate I-E expression between medullary epi-
thelial cells and thymic DC we carried out double immuno-
fluorescence analysis looking at the expression of the medul-
lary epithelial marker UEA-1 alone (Fig. 4, a, c, and e) or its
colocalization with the mAb specific for the transgenic I-E,
14.4.4S (Fig. 4, b, d, and f). UEA-1 positive medullary epi-
thelial cells were stained green, while the cells expressing
the I-E transgene stained red after detection with biotin-
Figure 1. Restriction map of the transgenic construct CD11c-Ea
d.
MHC class II I-Ea
d cDNA (striped box) was placed under the control of a
mouse CD11c promoter–containing DNA segment (gray box). The rabbit
b-globin gene fragment providing the cDNA with an intron and a poly-
adenylation signal (A(n)) is displayed as a white box. B, BamHI; Bs, BspHI;
E, EcoRI; N, NotI; S, SstI; X, XhoI; restriction sites in parentheses have
been destroyed by blunt-end cloning.
Figure 2. Serial cryostat sections of normal adult thymus stained with
14.4.4S specific for I-E (a, c, and e) and UEA-1 (b, d, and f), a lectin bind-
ing specific for medullary epithelial cells (28). (a and b) Serial sections of a
wild-type B6 (I-E2) thymus. (a) I-E, no I-E staining can be detected in
the B6 background, (b) UEA-1, staining is restricted to dense aggregates
of epithelial cells in the medulla (M), while no staining can be detected in
the cortex (C). (c and d) Serial sections of B6-Ea
d (I-E1) thymus, class II I-E
transgene staining is confluent on BM-derived and epithelial cells in the
medulla (M), and reticular staining in the cortex (C) is typical of epithelial
cells. UEA-1 staining (as in b) marking the medullary region (M) only.
(e and f ) Serial sections of B6CD11c-Ea
d thymus. I-E (e) transgene under
control of the CD11c promoter can be detected only in medulla (M) and
medullary-cortical junctions. No I-E staining in cortex (C) was detect-
able. UEA-1 (f) staining is the same as for b and d. All sections were pho-
tographed at 3100.544 The Role of Thymic Dendritic Cells
ylated mAb 14.4.4S plus avidin-TxR. While in the B6 thy-
mus, the medulla does not show I-E expression (Fig. 4, a
and b), and the B6-Ea
d medullary areas do express I-E (Fig.
4 d). In this case, the UEA-1–positive medullary epithelial
cells (Fig. 4 c, green staining) coexpress both markers and
consequently appear orange in the double fluorescence anal-
ysis (Fig. 4 d). Since UEA-1 produces very dense punctate
stainings of the cell center but very weak stainings of the
cell processes (36), only the central areas of epithelial cells
appear orange and the cell processes of these cells appear
red single positive (Fig. 4 d). In contrast, the UEA-1–posi-
tive medullary epithelial cells of the B6CD11c-Ea
d thymus
do not express I-E and only stain green (Fig. 4, e and f),
while red single positive cells of typical dendritic shape (ex-
tremely large elongated cells with long cell processes) ex-
press transgenic I-E (Fig. 4 f). An identical pattern has been
revealed with MTS-10 (27), another mAb specific for med-
ullary epithelial cells (data not shown) and confirmed the
absence of transgenic I-E on medullary epithelial cells.
To further characterize the cells expressing the I-E trans-
gene in the thymus, we isolated the light density cell frac-
tion from collagenase-digested thymi as described earlier (29),
and performed flow cytometric analysis. The major cell type
obtained in the low buoyant density fraction from thymus
were cells with relatively high forward scatter (FS) and in-
termediate side scatter (SS) signals (data not shown); in con-
trast, thymocytes (from the high density fraction) had both
low FS and SS (data not shown). When the low density frac-
tion was stained for CD11c expression, 80–90% of the cells
fulfilling the above described FS/SS criteria were CD11c-
positive (see Fig. 5, dendritic cells). While more than 60% of
the CD11c-positive cells from C57Bl/6 mice stained brightly
for MHC class II I-A molecules, they were all negative for
I-E (Fig. 5, B6). In contrast, the CD11c-positive cells from
B6-Ea
d mice were positive for I-A, but as expected, also
showed a remarkably high expression of transgenic I-E
molecules (Fig. 5, B6-Ea
d).
When the B6CD11c-Ea
d mice were analyzed (Fig. 5,
B6CD11c-Ea
d), we found a similar class II expression pat-
tern to the B6-Ea
d mice pattern; .70% of the CD11c-pos-
itive cells were both I-E– and I-A–positive. All three mouse
lines showed the presence of CD11c-positive thymic DC
that are low or negative for MHC class II expression. This
heterogeneous class II expression by DC has been described
Figure 3. Immunofluorescence staining of B6-Ea
d (a) and B6CD11c-Ea
d (b) thymus with the mAb 14.4.4S specific for I-E. While B6-Ea
d (a) shows a
typical reticular staining of cortical (C) epithelial cells, the B6CD11c-Ea
d thymus (b) does not display this pattern. Here, the I-E seems to be expressed
only in the medulla (M) and on cells of the cortico-medullary junction. Photographs were taken at 3200.
Figure 4. Immunofluorescence staining of B6 (a and b), B6-Ea
d (c and d), and B6CD11c-Ea
d (e and f) thymus with the medullary epithelial marker UEA-1
labeled with FITC (a, c, and e) or double immunofluorescence analysis with UEA-1–FITC plus 14.4.4S specific for I-E (biotinylated and detected with
Avidin-Texas red) (b, d, and f). The B6 thymus shows only green labeling (a and b) indicating the natural absence of I-E expression in this mouse strain.
The B6-Ea
d thymus (c and d) expresses both antigens in the wild-type pattern and the green UEA-1 positive cells (c) become yellow-orange in the double
fluorescence filter (d). In addition, red single positive cells become evident and are most likely nonepithelial cells expressing the I-E transgene as well as
UEA-1 weak positive cell processes of epithelial cells (36). In the B6CD11c-Ea
d thymus (e and f), both mAbs clearly stain two different cell types and no
I-E staining is visible on the UEA-1–labeled (green single positives) medullary epithelial cells (f), while other nonepithelial I-E positive cells (red single pos-
itives) of dendritic shape become evident in the medulla ( f ).545 Brocker et al.546 The Role of Thymic Dendritic Cells
earlier (23) and was then interpreted as indicating the pres-
ence of immature DC expressing lower levels of class II
MHC. In contrast to the I-A expression pattern of all three
mouse strains (Fig. 5, right), all CD11c-negative cells in the
B6CD11c-Ea
d mice were negative for I-E (Fig. 5, B6CD11c-
Ea
d) indicating the strictly controlled I-E expression pattern
by the CD11c promoter. Further analysis showed that the
I-E transgene in the B6CD11c-Ea
d strain is not expressed
on CD191 thymic B cells (Fig. 5, B cells, B6CD11c-Ea
d),
in contrast to the B6-Ea
d strain (Fig. 5, B cells, B6-Ea
d)
where thymic B cells express I-E and I-A.
Further, when we analyzed peritoneal macrophages after
IFN-g treatment for class II expression, only 2–7% of the
cells in these preparations showed I-E transgene expression,
while the majority of macrophages were I-E–negative like
the B6 control (Fig. 6, B6, B6CD11c-Ea
d). Analysis of
these I-E–positive cells showed that they were Mac-11,
Fcg III/II receptor1, B2202, CD192, and CD52 (data not
shown). This indicates that, most likely, some peritoneal
macrophages, but not peritoneal B cells, partially express
the I-E transgene. Since macrophages are equally distrib-
uted in thymic cortex where we could not detect I-E stain-
ing in the B6CD11c-Ea
d mice (see Fig. 2 e) and medulla
(36), the cells expressing the I-E transgene in the thymus of
the B6CD11c-Ea
d transgenic animals are most likely thy-
mic DC.
When we analyzed other lymphoid organs for transgene
expression, we found a selective I-E expression pattern that
was restricted to areas where DC are usually localized: in
the T cell areas of the splenic white pulp, in areas at the
margin of white and red pulp that are macrophage-free, and
in the paracortical T cell–rich areas of LN (data not shown).
In contrast, we could not detect I-E expression in B cell
follicles of spleen or LN, or in epidermal Langerhans cells.
Taken together, these results indicate, that the mouse
CD11c promoter, used to drive transgene expression in
B6CD11c-Ea
d mice, was in fact specifically active in CD11c-
positive dendritic cells. This transgenic model allowed us to
study the function of thymic DC in vivo.
I-E Expression Restricted to Thymic DC Mediates Clonal
Deletion of Vb51 and Vb111 T Cells In Vivo. The selective
expression of I-E on thymic DC, but not on cortical or
medullary epithelial cells, B cells, or macrophages, offered
an opportunity to investigate whether thymic dendritic cells
in vivo would be capable of inducing clonal deletion as re-
ported for DC from spleen (6, 9, 37) or GM-CSF–cultured
thymic DC (16) in vitro. On the other hand, we were now
able to test if they really could not induce negative selec-
tion in the absence of I-E1 thymic B cells as initially postu-
lated by Mazda et al. (9). To assess in vivo clonal deletion,
we measured the frequency of I-E reactive Vb51 and
Vb111 T cells in B6, B6-Ea
d, and B6CD11c-Ea
d mice.
T cells expressing Vb5 and Vb11 genes were deleted in
certain mouse strains that expressed I-E (38, 39) and retro-
virally encoded superantigens in the thymus (40). Because
B6 mice do not express functional I-E molecules, the fre-
quency among total CD41 cells of both Vb5- and Vb11-
expressing CD41 T cells is z4%, and z15 and 6%, respec-
tively, in the CD81 population (Fig. 7). In I-E transgenic
mice, the efficiency of clonal deletion was reported to be
maximal when the transgene was expressed on both thymic
epithelium and BM-derived cells (41, 42). This situation
was reflected in the case of the B6-Ea
d mouse. In compari-
son with B6 mice, and as reported earlier (43) in this mouse
strain, 65% of CD41Vb51 T cells and .95% of Vb111
CD41 T cells were deleted (Fig. 7). In the CD8 compart-
ment, a strong but less complete deletion was also observed
(83% deletion of Vb51 and 64% deletion of Vb111 T cells).
In T cells from the B6 CD11c-Ea
d strain, we found a simi-
lar degree of deletion in the CD4 (63% Vb51 deletion,
Figure 5. Expression of the
CD11c-Ea
d transgene leads to I-E
expression on thymic DC, but
not on thymic B cells. DC:
Thymi of B6, B6-Ea
d, and
B6CD11c-Ea
d mice were colla-
genase digested and DC were
isolated after a low density gradi-
ent as described in Materials and
Methods. Cells were stained with
mAbs specific for CD11c (PE)
and I-E or I-A (FITC), respec-
tively. B cells: thymi of the three
mouse types were complement
depleted for CD4 and CD8 to
enrich non–T cells (see Materials
and Methods) and then stained
with mAbs specific for the pan B
cell antigen CD19 (PE) and I-E
or I-A (FITC), respectively.547 Brocker et al.
85% Vb111 deletion) and sigificant, but less complete, de-
letion in the CD8 subset (75% Vb51 deletion and 32%
Vb111 deletion) (Fig. 7). The efficiency of deletion in the
CD4 compartment seems to be identical for the two situa-
tions studied. It is important to note that the absence of I-E
expression on both thymic epithelium and thymic B cells
in the B6CD11c-Ea
d thymus does not markedly reduce the
efficiency of clonal deletion. This correlates with earlier
studies using reaggregated organ cultures containing splenic
DC as BM-derived cells, showing that professional APC
clonally delete T cells much more efficiently than thymic
epithelium (6). Also, in BM reconstitution experiments,
Burkly et al. (43) showed that when I-E is expressed only
on medullary epithelium, negative selection is only partial.
Our results support the notion that thymic DC are the
most potent cell type in eliminating self-reactive T cells and
that I-E expression on the epithelium or other BM-derived
cells seems not to be necessary for complete clonal elimina-
tion of I-E-reactive T cells in the CD41 compartment.
Since the deletion observed in the CD8 T cell compart-
ment of B6CD11c-Ea
d mice is less efficient than in the
control situation (B6-Ea
d), other cell types might be in-
volved in deletion of CD81 I-E reactive T cells, while
BM-derived DC are sufficient to eliminate CD41 I-E reac-
tive T cells.
Thymic DC Are Not Able to Mediate Positive Selection In
Vivo. In earlier reports, targeted expression of class II
molecules in transgenic mice showed that positive selection
occurred only if the appropriate MHC molecules were
present on cortical epithelium (and some medullary DC)
(44), whereas if class II was only expressed on medullary
epithelium and medullary BM-derived cells, no (45) or
very little (46) positive selection was observed. Since in all
of these experiments the transgene was expressed on multi-
ple cell types, the B6CD11c-Ea
d strain provided the possi-
bility to investigate the precise role of DC in positive selec-
tion in vivo.
To this end we crossed the above described mouse
strains to the I-A2/2 line described earlier (47). When
the I-A–deficient background was combined with the nat-
ural defect of I-E expression in C57BL/6 mice, this strain
showed absence of all MHC class II molecules, and conse-
quently, the absence of CD41 mature T cells in thymus
and periphery (47; Fig. 8, B6I-A2/2). When the I-E gene
was reintroduced into these mice under the control of the
class II promoter, the reexpression of class II (I-E) on thy-
mic epithelium and BM-derived cells led to the full resto-
ration of the mature CD41 T cell compartment (Fig. 8,
B6-Ea
dI-A2/2) as it has been described before (46). In con-
trast, when I-E expression was restricted to thymic DC
(Fig. 8, B6CD11c-Ea
dI-A2/2), restoration of the CD41 com-
partment was not observed; the percentages of CD41 T
cells were identical to those of B6I-A2/2 mice (see legend
Figure 6. The majority of peritoneal lavage cells do not express the
CD11c-Ea
d transgene. Peritoneal washes of the mice indicated were per-
formed 5 d after an initial intraperitoneal injection of 2 ml 3% thioglycol-
late. The isolated cells were incubated for 48 h in IFN-g–containing me-
dium (1,000 U/ml) to induce MHC class II expression, and then stained
with mAbs specific for I-E (PE) and I-A (FITC). Shown are all cells from
the cultures with the gates set on live cells only. The percentages of I-E
positive cells in B6CD11c-Ea
d mice varied from 2–7% in the four experi-
ments done.
Figure 7. Clonal deletion of T cells as a consequence of Ea
d transgene
expression. Flow cytometric analysis of Vb8, Vb5, and Vb11 expression
among CD41 and CD81 LN T cells. B cell–depleted LN cells of the
three indicated mouse strains (n 5 8/strain) were triple stained with anti–
CD4-PE, anti–CD8-R613, and either anti–Vb8.1,8.2-FITC, Vb5.1,5.2-
FITC, or Vb11-FITC, respectively. Results are expressed as a percentage
of Vb1CD41 and Vb1CD81 cells.548 The Role of Thymic Dendritic Cells
to Fig. 8). Cosgrove et al. (46) have described that their DX
mice, expressing I-E on epithelial and BM-derived cells in
the medulla but not in the cortex, showed a slight increase
in CD41 T cells when bred with the I-A2/2–deficient
background. The authors interpreted their findings by in-
voking a leaky expression pattern of the I-E transgene
which would eventually be expressed at an albeit low, his-
tochemically undetectable, level on cortical epithelium.
Since we do not see such an increase in CD41 T cells
when I-E was expressed exclusively on thymic DC, our
findings argue (a) in support of the strictly defined expres-
sion pattern of the CD11c-Ea
d construct to DC and (b) that
medullary epithelium could theoretically be responsible for
the weak positive selection effect of CD41 T cells de-
scribed by others (46). Furthermore, the complete absence
of positively selected CD41 T cells in our B6CD11c-Ea
dI-
A2/2 strain confirms previous observations (14, 15) ob-
tained using different in vitro experimental protocols, in-
dicating that thymic dendritic cells in vivo are not able to
induce MHC restriction of CD41 T cells.
The 5.5-kb fragment of the mouse CD11c 59 region
seems to provide us with regulatory elements that drive ex-
pression of transgenes specifically in DC and not in other
cell types. It might be a powerful tool, enabling us to study
the roles of DC at their natural locations, avoiding complex
DC isolation/culture methods, and artificial experimental
setups.
Figure 8. Influence of the Ea
d transgenes on the number of CD41 T cells. LN and thymus cell suspensions were stained with PE-labeled anti-CD4
and FITC-labeled anti-CD8 mAbs. The CD4/CD8 ratios in the LN T lymphocyte populations were determined from 5 mice per group and the follow-
ing values were obtained: B6I-A1/1, 3.03 6 0.07; B6I-A2/2, 0.031 6 0.004; B6-Ea
dI-A2/2, 2.94 6 0.05; B6CD11c-Ea
dI-A2/2, 0.04 6 0.006. The per-
centages of CD41CD82 thymocytes in the thymi of the same animals were: B6I-A1/1, 8.61 6 0.71%; B6I-A2/2, 1.06 6 0.03%; B6-Ea
dI-A2/2, 6.96 6
0.51%; B6CD11c-Ea
dI-A2/2, 0.77 6 0.132%.
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